Chen Ying, Zhang Dan
Department of Obstetrics and Gynecology,West China Second University Hospital,Sichuan University,Key Laboratory of Birth Defects and Related Disease of Women and Children (Sichuan University),Ministry of Education,Chengdu 610041,China.
Institute of Reproductive,Chengdu Women and Children's Central Hospital,Chengdu 610091,China.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2016 Nov;47(6):874-877.
To investigate the optimal ovulation induction with the combination of combining letrozole(LE),clomiphene citrate (CC),and human menopausal gonadotropin (HMG) in polycystic ovary syndrome(PCOS) patients resistant to CC or LE.
Two hundreds nine PCOS patients (209 cycles) resistant to CC or LE were randomly divided into three groups: CC+HMG group (59 cycles),LE+HMG group (72 cycles) and LE+CC group (78 cycles).The patients in LE+CC group unable to form the dominant follicle after 54 cycles were enrolled into LE+CC+HMG group.Maximum follicle diameter (MFD),endometrial thickness,number of follicles (diameter>1.4 cm),the level of serum estradiol (E2) were measured on the day of HMG administration.Also these results were observed and compared including the duration of treatment,dosage of HMG,number of ovulated follicles,clinical pregnancy rate,biochemical pregnancy rate,early abortion rate,twinning rate,and ectopic pregnancy rate.
The ovulation rate was significantly lower in LE+CC group (30.77%) (<0.05),but similar in the other three groups.The number of >1.4 cm follicles and ovulated follicles,ovulation duration and E2 concentration in LE+CC group were also at a lower level (<0.05).The patients in LE+CC+HMG group showed higher E2 level and more HMG consumption (<0.05).There was no statistical difference in endometrial thickness,MFD,clinical pregnancy rate,biochemical pregnancy rate,early abortion rate and twinning rate among these groups (>0.05).No severe ovarian hyperstimulation syndrome (OHSS) or luteinized unruptured follicle (LUF) occurred.
Combintion of LE with CC could achieve 1/3 ovulation induction in PCOS resistant to CC or LE alone.When both combined with HMG,the induction of ovulation could be significantly higher than LE+HMG and CC+HMG,while the risk of multiple pregnancy and OHSS was reduced.
探讨来曲唑(LE)、枸橼酸氯米芬(CC)与人绝经期促性腺激素(HMG)联合应用于对CC或LE耐药的多囊卵巢综合征(PCOS)患者的最佳促排卵方案。
将209例对CC或LE耐药的PCOS患者(209个周期)随机分为三组:CC+HMG组(59个周期)、LE+HMG组(72个周期)和LE+CC组(78个周期)。将LE+CC组中54个周期后未能形成优势卵泡的患者纳入LE+CC+HMG组。在给予HMG当天测量最大卵泡直径(MFD)、子宫内膜厚度、卵泡数量(直径>1.4 cm)、血清雌二醇(E2)水平。同时观察并比较治疗持续时间、HMG剂量、排卵卵泡数量、临床妊娠率、生化妊娠率、早期流产率、双胎率和异位妊娠率等结果。
LE+CC组排卵率显著低于其他三组(30.77%)(<0.05),但其他三组相似。LE+CC组中直径>1.4 cm的卵泡数量、排卵卵泡数量、排卵持续时间和E2浓度也处于较低水平(<0.05)。LE+CC+HMG组患者E2水平较高,HMG消耗量较多(<0.05)。各组间子宫内膜厚度、MFD、临床妊娠率、生化妊娠率、早期流产率和双胎率无统计学差异(>0.05)。未发生严重卵巢过度刺激综合征(OHSS)或未破裂卵泡黄素化(LUF)。
LE与CC联合应用可使单独对CC或LE耐药的PCOS患者中有1/3实现促排卵。当两者都与HMG联合应用时,促排卵效果显著高于LE+HMG和CC+HMG,同时降低了多胎妊娠和OHSS的风险。